You are seeing these quotes based on previous browsing related to sectors such as
Name | Value | 1 Day Chg | 7 Day Chg | 14 Day Chg | 30 Day Chg | 90 Day Chg | Beta |
---|---|---|---|---|---|---|---|
4basebio | n/a | -1.56% | 3.27% | 3.27% | 1.67% | -5.28% | 0.3 |
4D Pharma | n/a | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | n/a |
Abcam | 134 | 0.00% | -3.24% | -2.23% | -14.03% | -9.39% | n/a |
Abzena | n/a | 0.00% | 0.00% | 0.00% | 0.00% | 93.25% | n/a |
Agronomics Limited | 475 | -1.27% | -2.50% | -4.41% | -17.02% | -29.73% | 0.2 |
Allergy Therapeutics | 268 | 0.00% | -5.23% | -4.55% | 7.58% | 12.90% | 0.2 |
Alliance Pharma | 119 | -1.49% | -2.21% | 3.11% | 1.75% | 25.75% | 1.1 |
Animalcare Group | n/a | 0.00% | 1.28% | 0.00% | 0.42% | -12.82% | -0.4 |
Anpario | n/a | 0.42% | 1.84% | 12.19% | 18.68% | 39.42% | -0.4 |
Aptamer Group | n/a | -1.18% | -1.75% | 24.44% | 27.27% | 21.74% | 0.5 |
Aqua Bounty Technologies Inc. (Reg S) | n/a | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | n/a |
Arecor Therapeutics | n/a | 0.66% | 0.66% | 2.00% | 3.38% | -16.39% | 0.1 |
Argent Biopharma Limited NPV (DI) | n/a | 3.03% | 3.03% | 3.03% | -24.44% | 47.83% | n/a |
AstraZeneca | 123 | -0.98% | -1.05% | -10.52% | -17.29% | -24.27% | 0.9 |
Avacta Group | 461 | 8.63% | -2.12% | -4.95% | -18.30% | -29.89% | 1.2 |
Benchmark Holdings | n/a | 0.00% | -1.20% | -1.34% | -9.33% | -1.07% | 0.4 |
Beximco Pharmaceuticals Ltd. GDR (Reg S) | 190 | 1.08% | -5.05% | -0.53% | -2.08% | -5.05% | n/a |
Biodexa Pharmaceuticals | 386 | 0.00% | -21.05% | -31.82% | -80.26% | -90.38% | n/a |
Biofrontera AG (DI) | n/a | 0.00% | 1.75% | 1.75% | 1.75% | -1.69% | n/a |
Bioventix | n/a | 0.22% | 2.00% | 4.79% | 3.38% | -13.07% | -0.3 |
BiVictriX Therapeutics | n/a | 0.00% | 33.33% | 17.65% | -23.08% | -16.67% | n/a |
BTG | n/a | 0.00% | 0.12% | 0.30% | 0.42% | 0.60% | n/a |
C4X Discovery Holdings | n/a | 0.00% | 40.35% | 24.03% | -9.09% | -11.44% | n/a |
Chill Brands Group | 489 | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | n/a |
Cizzle Biotechnology Holdings | n/a | 0.00% | -8.77% | -13.33% | -11.11% | 5.05% | 0.7 |
Cyprotex | n/a | 0.00% | 0.63% | 0.78% | 1.26% | 8.81% | n/a |
Dechra Pharmaceuticals | 121 | 0.00% | 0.16% | 0.26% | 0.68% | 1.90% | n/a |
Deepverge Plc | 427 | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | n/a |
Destiny Pharma | 410 | 0.00% | -29.41% | 9.09% | -64.71% | -82.35% | n/a |
Diurnal Group | n/a | 0.00% | 0.00% | 0.00% | 0.55% | 176.46% | n/a |
e-Therapeutics | n/a | 0.00% | -7.93% | -1.91% | -22.08% | -40.00% | n/a |
EastPharma Ltd GDR (Reg S) | n/a | 0.00% | -14.29% | -60.00% | 9.09% | 9.09% | n/a |
ECO Animal Health Group | n/a | 0.00% | -8.87% | -10.71% | -10.71% | -29.34% | -0.3 |
Eden Research | n/a | 1.90% | -2.28% | -6.14% | -7.36% | -18.01% | -0.1 |
Ergomed | n/a | 0.00% | 0.15% | 0.30% | 0.90% | 22.14% | n/a |
Faron Pharmaceuticals Oy (DI) | n/a | 0.00% | -9.98% | -9.98% | -30.59% | -16.32% | 1.7 |
Futura Medical | 479 | -1.32% | -11.24% | -11.71% | 1.67% | 0.60% | 1.4 |
Genflow Biosciences | n/a | 0.00% | -1.11% | -1.11% | -2.47% | -19.09% | 0.5 |
Genus | 128 | -1.63% | -9.03% | -18.06% | -19.43% | -2.65% | 1.5 |
Graft Polymer (UK) | n/a | -8.82% | 29.17% | 42.53% | 42.53% | 5.98% | 0.7 |
GSK | 129 | 0.58% | -6.34% | -7.46% | -11.35% | -17.76% | 0.5 |
Gunsynd | 527 | 0.00% | 2.08% | 6.52% | 2.08% | -18.33% | 0.4 |
GW Pharmaceuticals | n/a | 0.00% | -8.13% | -7.72% | -3.35% | 42.30% | n/a |
Haleon | n/a | -0.11% | 0.55% | -1.64% | -4.19% | -1.22% | 0.4 |
Hemogenyx Pharmaceuticals | 340 | 12.42% | 16.29% | 1.81% | -4.39% | -2.39% | 0.7 |
Hikma Pharmaceuticals | 125 | 0.00% | -1.14% | -2.16% | -9.11% | -12.27% | 0.6 |
Horizon Discovery Group | n/a | 0.00% | 0.00% | -1.34% | -4.90% | 86.36% | n/a |
HUTCHMED (China) Limited | 226 | 1.14% | -3.26% | -7.29% | -14.42% | -7.29% | 1.4 |
Hvivo | n/a | 0.00% | 18.92% | 37.50% | 34.69% | 1.54% | n/a |
Immupharma | 328 | 4.01% | 5.90% | 10.94% | -9.56% | 0.43% | 0.5 |
Indivior | 314 | -2.06% | -5.13% | 8.43% | 16.23% | -20.23% | 1.6 |
Ixico | n/a | 9.76% | 9.47% | 0.83% | 0.83% | 0.83% | 0.1 |
LungLife AI, Inc (DI) | n/a | 0.00% | 0.00% | 0.00% | -13.27% | -32.00% | -0.4 |
Maxcyte Inc (DI/REG S) | 330 | 0.00% | 0.00% | 0.00% | 3.93% | -5.13% | n/a |
Mereo Biopharma Group | n/a | 0.00% | -10.17% | -22.06% | -18.46% | -42.39% | n/a |
Motif Bio | n/a | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | n/a |
N4 Pharma | n/a | 0.00% | -5.13% | -14.94% | 2.78% | 12.12% | n/a |
Nuformix | 322 | 0.00% | -1.96% | -8.26% | -20.00% | -71.83% | 0.1 |
Okyo Pharma Limited NPV | 403 | 0.00% | -31.71% | -30.00% | -9.68% | -74.07% | n/a |
Ondine Biomedical Inc. NPV (CDI) | n/a | 3.90% | 3.90% | 0.84% | 29.38% | 18.23% | 0.9 |
OptiBiotix Health | n/a | -2.96% | 4.80% | 27.80% | 0.77% | -48.63% | 0.6 |
Ovoca Bio (CDI) | n/a | 0.00% | 0.00% | -2.70% | 20.00% | 111.76% | 0.2 |
Oxford Biomedica | 125 | 0.49% | -1.79% | 0.74% | 3.92% | 15.94% | 1.2 |
Oxford Cannabinoid Technologies Holdings | n/a | 0.00% | -43.90% | -36.11% | -66.67% | -73.86% | n/a |
Oxford Nanopore Technologies | n/a | -5.50% | -10.49% | -10.36% | -13.68% | -2.29% | 1.3 |
Pfizer Inc. | n/a | 0.00% | 17.46% | 17.46% | 17.46% | 17.46% | n/a |
OJSC Pharmstandard GDR (Reg S) | n/a | 0.00% | -1.75% | 2.89% | -2.00% | 3.16% | n/a |
Plethora Solutions Holdings | n/a | 0.00% | -11.11% | -11.11% | 9.09% | -33.33% | n/a |
Poolbeg Pharma | n/a | -1.68% | -6.29% | -6.82% | -1.20% | -35.94% | 0.8 |
Proteome Sciences | 353 | 0.00% | 0.00% | 3.77% | -2.14% | -21.43% | 0.6 |
PureTech Health | n/a | -4.43% | -2.96% | 2.50% | 8.90% | -3.53% | 1.0 |
Quantum Pharma | n/a | 0.00% | 2.74% | 2.43% | 2.74% | 52.49% | n/a |
Redx Pharma | 278 | 0.00% | 46.34% | 36.36% | -18.92% | -25.00% | n/a |
ReNeuron Group | 394 | 0.00% | -2.96% | -2.96% | -2.96% | -2.96% | n/a |
Sareum Holdings | 594 | 2.74% | 1.01% | -3.85% | -7.41% | -16.67% | -0.2 |
Scancell Holdings | n/a | -4.24% | 14.91% | 18.13% | 17.04% | -5.95% | 0.4 |
Shield Therapeutics | n/a | 0.00% | 0.93% | -3.57% | -40.66% | -28.95% | 1.8 |
Shire Plc | n/a | 0.00% | 2.63% | 4.36% | 3.42% | 6.88% | n/a |
Silence Therapeutics | 177 | 0.00% | -1.65% | -0.93% | 5.94% | -9.17% | n/a |
Sinclair Pharma | n/a | 0.00% | 0.00% | 0.32% | 0.47% | 45.21% | n/a |
SkinBioTherapeutics | n/a | 4.20% | -1.71% | -8.73% | -4.17% | 11.65% | 1.3 |
Skyepharma | n/a | 0.00% | -1.94% | -4.47% | -6.39% | 17.35% | n/a |
Source BioScience | n/a | 0.00% | -4.11% | -1.41% | -1.41% | 2.19% | n/a |
Summit Therapeutics | n/a | 0.00% | -2.38% | -12.77% | -2.38% | -6.82% | n/a |
Synairgen | 510 | 2.28% | 7.64% | 3.57% | 2.92% | 33.24% | 1.5 |
Taihua | n/a | 0.00% | -30.00% | 59.09% | -46.15% | -72.00% | n/a |
Theracryf | 304 | 0.00% | -15.00% | -15.00% | -18.40% | -27.14% | 0.9 |
Tiziana Life Sciences | n/a | 0.00% | 11.43% | 12.50% | 7.34% | -7.87% | n/a |
Valirx | 435 | 15.89% | 1.64% | -8.82% | 24.00% | -35.42% | -0.9 |
Vectura Group | 139 | 0.00% | 0.12% | -0.12% | 0.00% | 6.74% | n/a |
Verici DX | 429 | 21.79% | 8.26% | 4.40% | -14.03% | -47.05% | 0.2 |
Vernalis plc | n/a | 0.00% | 0.49% | 0.33% | 0.82% | -4.19% | n/a |
Verona Pharma | n/a | 0.00% | 4.76% | 4.76% | -15.38% | -24.14% | n/a |
Verseon Corporation (DI/REG S) | n/a | 0.00% | 96.72% | 73.91% | -48.94% | -67.74% | n/a |
Verseon Corporation (Reg S Cat 3) | n/a | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | n/a |
Yourgene Health | n/a | 0.00% | 0.98% | 0.98% | 5.10% | 139.53% | n/a |